What Is Tirzepatide? Dual GIP/GLP-1 Research Peptide

Tirzepatide is one of the most-studied compounds in metabolic peptide research and the defining example of a dual incretin agonist. Where earlier compounds engaged a single receptor, tirzepatide activates two — a design that made it a distinct generation of research compound. This overview explains what tirzepatide is, the receptors it targets, and the research context. For in-vitro laboratory research only.

What is tirzepatide?

Tirzepatide is a synthetic peptide built on a GIP-based backbone that also engages the GLP-1 receptor, making it a unimolecular dual agonist. It belongs to the incretin-mimetic class. Its two-receptor design is the reason it is studied as a separate category from single-agonist GLP-1 compounds. The tirzepatide research kit is supplied lyophilized in multi-vial research kits.

What receptors does tirzepatide target?

Tirzepatide is a dual agonist of two incretin receptors:

• GIP receptor (glucose-dependent insulinotropic polypeptide) — studied for insulin secretion and lipid-handling pathways
• GLP-1 receptor (glucagon-like peptide-1) — central to appetite-regulation and glucose-dependent insulin-signaling models

Unlike semaglutide, which targets GLP-1 alone, tirzepatide adds GIP-receptor activity. Unlike retatrutide, it stops at two receptors and does not engage the glucagon receptor — placing it squarely between the two in the dual-agonist tier.

Mechanism class: why dual agonism matters in research

Both GIP and GLP-1 are incretin hormones, but they act through different receptors and signaling profiles. By engaging both in a single molecule, tirzepatide lets researchers study whether simultaneous activation of two incretin pathways changes measured outcomes versus single-receptor GLP-1 agonism. This question — does multi-receptor engagement matter — is the core reason tirzepatide is such a frequent comparator. The full single-vs-dual breakdown is in semaglutide vs tirzepatide.

What is tirzepatide studied for?

As a reference standard, tirzepatide is used in receptor-binding and signaling assays to characterize potency and selectivity at the GIP and GLP-1 receptors. In broader metabolic models it appears in appetite-regulation, insulin-signaling, and energy-expenditure research. It is a standing comparator against both the single-agonist and triple-agonist tiers of the cluster.

How the research kit is supplied

Tirzepatide is supplied lyophilized in multi-vial research kits, shipping from our US facility within 48 hours with tracking. Reconstitution with bacteriostatic water is handled with the reconstitution calculator, which returns concentration and aliquot volumes. Order the tirzepatide reference standard or browse the wider weight & metabolic category.